Cargando…
Is SARS-CoV-2 a Risk Factor of Bipolar Disorder?—A Narrative Review
For 2.5 years we have been facing the coronavirus disease (COVID-19) and its health, social and economic effects. One of its known consequences is the development of neuropsychiatric diseases such as anxiety and depression. However, reports of manic episodes related to COVID-19 have emerged. Mania i...
Autores principales: | Lorkiewicz, Piotr, Waszkiewicz, Napoleon |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9604904/ https://www.ncbi.nlm.nih.gov/pubmed/36294388 http://dx.doi.org/10.3390/jcm11206060 |
Ejemplares similares
-
Biomarkers of Post-COVID Depression
por: Lorkiewicz, Piotr, et al.
Publicado: (2021) -
Old and New Biomarkers of Alcohol Abuse: Narrative Review
por: Fakhari, Sara, et al.
Publicado: (2023) -
Markers of Schizophrenia—A Critical Narrative Update
por: Galińska-Skok, Beata, et al.
Publicado: (2022) -
Biomarkers of Postpartum Depression: A Narrative Review
por: Modzelewski, Stefan, et al.
Publicado: (2023) -
Sibutramine-induced mania as the first manifestation of bipolar disorder
por: Waszkiewicz, Napoleon, et al.
Publicado: (2012)